BiotechTube
Kern Pharma

Kern Pharma

Terrassa, Spain· Est.
kernpharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Kern Pharma is a well-established, privately-held Spanish pharmaceutical company specializing in generic drugs and biosimilars. With a portfolio of over 230 products and a strong manufacturing base, it serves the Spanish market and has expanded internationally through subsidiaries in Portugal and the US, as well as exports across the EU. The company leverages its expertise in development and production to maintain a broad product portfolio and offers contract manufacturing services to other industry players, supported by a team of over 940 professionals.

Broad Portfolio (Generics)Women's HealthSports NutritionVarious via Biosimilars

Technology Platform

Expertise in development and manufacturing of small-molecule generic drugs and biosimilar biologics, including robust process chemistry, bioequivalence testing, bioprocessing, and GMP-compliant production.

Funding History

1
UndisclosedUndisclosed

Opportunities

Strong global demand for cost-effective generics and biosimilars driven by healthcare cost containment.
Growth in the CDMO (contract manufacturing) sector offers a complementary revenue stream.
International expansion through subsidiaries (US, Portugal) and EU-wide distribution opens new markets.

Risk Factors

Intense price competition and margin pressure in the generic drug sector.
High regulatory and development complexity, particularly for biosimilars, including patent litigation risk.
Dependence on patent expirations for new product opportunities and exposure to geopolitical/regulatory changes in export markets.

Competitive Landscape

Operates in the highly competitive global generic and biosimilar markets, competing against large multinationals (e.g., Teva, Sandoz, Viatris) and other European specialists. Differentiation is based on portfolio breadth, manufacturing reliability, cost competitiveness, and successful biosimilar development.

More companies in Biologics / Biosimilars →More companies in Spain →